KalVista Pharmaceuticals Inc (NASDAQ:KALV)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting -0.01. At the close of
In last trading session, KalVista Pharmaceuticals Inc (NASDAQ:KALV) saw 0.41 million shares changing hands with its beta currently measuring -0.02. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne